Quality of life improvements in patients with active relapsing-remitting multiple sclerosis are not impacted by acute infections after receiving alemtuzumab in CARE-MS II

Affiliation auteursAffiliation ok
TitreQuality of life improvements in patients with active relapsing-remitting multiple sclerosis are not impacted by acute infections after receiving alemtuzumab in CARE-MS II
Type de publicationJournal Article
Year of Publication2015
AuteursVermersch P., Giovannoni G., Cohen J.A, Moreau T., Wray S., Margolin D.H, Kasten L., Investigators CARE-MSII
JournalMULTIPLE SCLEROSIS JOURNAL
Volume21
Pagination621
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN1352-4585